Clinical Trial: A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312851) titled 'A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants' on Nov. 27, 2025.

Brief Summary: The purpose of this study is to characterize andexanet posology and interaction between andexanet and enoxaparin post infusion in healthy participants.

Study Start Date: Jan. 12

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Andexanet alfa

Andexanet alfa will be administered as an intravenous bolus followed by an infusion, however, in Module 3, only a bolus will be given.

DRUG: Rivaroxaban

Rivaroxaban will be administered as an oral t...